Clinical Trial Update: Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating lidocaine as an opioid-sparing treatment for vaso-occlusive crises in sickle cell disease; the study is currently not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: Nantes University Hospital | Conditions: Vaso-Occlusive Pain Episode in Sickle Cell Disease | Phase 3 | Status: NOT_YET_RECRUITING